The Epidemiology and Effects of Cardiovascular Risk Factors in Athletes

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".

Deadline for manuscript submissions: 20 September 2024 | Viewed by 806

Special Issue Editors


E-Mail Website
Guest Editor
1. Institute of Sports Medicine and Science, National Italian Olympic Committee, Largo Piero Gabrielli, 00197 Rome, Italy
2. Unit of Cardiovascular Science, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 00128 Rome, Italy
3. Department of Movement, Human and Health Sciences, University of Rome “Foro Italico”, Piazza Lauro de Bosis, 00135 Rome, Italy
Interests: athlete’s heart; cardiomyopathies; dyslipidemia; hypertension; heart remodeling

E-Mail Website
Guest Editor
Department of Sports Medicine, Institute of Sports Medicine and Science, National Italian Olympic Committee, Largo Piero Gabrielli, 1, 00197 Rome, Italy
Interests: athlete’s heart; heart remodeling; athletes; exercise prescription; Olympic

E-Mail Website
Guest Editor
Unit of Cardiovascular Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy
Interests: cardiac surgery; myocardial revascularization; angiogenesis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The number of people that exercise is continuously increasing worldwide thanks to preventive communication campaigns promoting a healthy lifestyle. Both in professional and recreational athletes, the cardiovascular risk profile and estimated protection of continuous exercise tend to be underestimated and undertreated, particularly in younger athletes. However, in last the few years, several studies on athletes have showed a concrete prevalence of hypertension, lipid disorders or less-studied alterations in metabolic parameters (i.e., iperuricemia, thyroid function, overweight metabolic consequences). Moreover, less have investigated environmental and clinical factors that need to be evaluated to better understand the influence of these factors on heart adaptation to exercise and reducing the future development of cardiovascular diseases. The aim of this Special Issue is to highlight the influence of cardiovascular risk factors on athlete’s health and their performance in exercise.

Dr. Giuseppe Di Gioia
Dr. Maria Rosaria Squeo
Dr. Antonio Nenna
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • athletes
  • dyslipidemia
  • hypertension
  • cholesterol
  • prevention
  • risk factors
  • sport cardiology

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 659 KiB  
Article
Prevalence of Hyperuricemia and Associated Cardiovascular Risk Factors in Elite Athletes Practicing Different Sporting Disciplines: A Cross-Sectional Study
by Giuseppe Di Gioia, Simone Pasquale Crispino, Viviana Maestrini, Sara Monosilio, Maria Rosaria Squeo, Erika Lemme, Andrea Segreti, Andrea Serdoz, Roberto Fiore, Domenico Zampaglione and Antonio Pelliccia
J. Clin. Med. 2024, 13(2), 560; https://doi.org/10.3390/jcm13020560 - 18 Jan 2024
Viewed by 609
Abstract
Uricemia has been identified as an independent risk factor for cardiovascular disease. In the general population, hyperuricemia is associated with hypertension, endothelial dysfunction, and other cardiovascular risk (CVR) factors. Our aim was to explore the prevalence of hyperuricemia among Olympic athletes, evaluating the [...] Read more.
Uricemia has been identified as an independent risk factor for cardiovascular disease. In the general population, hyperuricemia is associated with hypertension, endothelial dysfunction, and other cardiovascular risk (CVR) factors. Our aim was to explore the prevalence of hyperuricemia among Olympic athletes, evaluating the influence of sporting discipline and its correlation with CVR factors. We enrolled 1173 Olympic athletes classified into four disciplines: power, skill, endurance, and mixed. Clinical, anthropometric data, and complete blood test results were collected. Hyperuricemia was present in 4.4% of athletes, 0.3% were hypertensive, 11.7% had high-normal blood pressure values, 0.2% were diabetic, 1.2%. glucose intolerance, 8.2% active smokers, and 3% were obese. Males had a higher prevalence of hyperuricemia (5.3%) than females (3.4%) with no significant differences between different sporting disciplines (male, p = 0.412; female p = 0.561). Males with fat mass >22% presented higher uricemia (5.8 ± 1 vs. 5.3 ± 1 mg/dL, p = 0.010) like hypertensive athletes (6.5 ± 0.3 vs. 5.3 ± 1 mg/dL, p = 0.031), those with high-normal blood pressure (5.13 ± 1 vs. 4.76 ± 1.1 mg/dL, p = 0.0004) and those with glucose intolerance (6 ± 0.8 vs. 5.3 ± 1 mg/dL, p = 0.066). The study provides a comprehensive evaluation of hyperuricemia among Olympic athletes, revealing a modest prevalence, lower than in the general population. However, aggregation of multiple CVR factors could synergistically elevate the risk profile, even in a population assumed to be at low risk. Therefore, uric acid levels should be monitored as part of the CVR assessment in athletes. Full article
Show Figures

Figure 1

Back to TopTop